Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC26018026;8027;8028 chr2:178773163;178773162;178773161chr2:179637890;179637889;179637888
N2AB26018026;8027;8028 chr2:178773163;178773162;178773161chr2:179637890;179637889;179637888
N2A26018026;8027;8028 chr2:178773163;178773162;178773161chr2:179637890;179637889;179637888
N2B25557888;7889;7890 chr2:178773163;178773162;178773161chr2:179637890;179637889;179637888
Novex-125557888;7889;7890 chr2:178773163;178773162;178773161chr2:179637890;179637889;179637888
Novex-225557888;7889;7890 chr2:178773163;178773162;178773161chr2:179637890;179637889;179637888
Novex-326018026;8027;8028 chr2:178773163;178773162;178773161chr2:179637890;179637889;179637888

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAA
  • RefSeq wild type template codon: TTT
  • Domain: Ig-15
  • Domain position: 69
  • Structural Position: 153
  • Q(SASA): 0.4242
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/N rs988264686 -0.622 0.007 N 0.321 0.072 0.184867976434 gnomAD-2.1.1 3.99E-06 None None None None N None 0 2.9E-05 None 0 0 None 0 None 0 0 0
K/N rs988264686 -0.622 0.007 N 0.321 0.072 0.184867976434 gnomAD-4.0.0 1.59113E-06 None None None None N None 0 2.28802E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.1247 likely_benign 0.1533 benign -0.727 Destabilizing 0.004 N 0.247 neutral None None None None N
K/C 0.4701 ambiguous 0.5411 ambiguous -0.708 Destabilizing 0.788 D 0.488 neutral None None None None N
K/D 0.1581 likely_benign 0.1883 benign -0.054 Destabilizing None N 0.176 neutral None None None None N
K/E 0.0545 likely_benign 0.0688 benign 0.051 Stabilizing None N 0.119 neutral N 0.294296712 None None N
K/F 0.4689 ambiguous 0.5121 ambiguous -0.5 Destabilizing 0.138 N 0.581 neutral None None None None N
K/G 0.2244 likely_benign 0.2666 benign -1.082 Destabilizing 0.018 N 0.295 neutral None None None None N
K/H 0.203 likely_benign 0.2361 benign -1.419 Destabilizing 0.138 N 0.467 neutral None None None None N
K/I 0.1075 likely_benign 0.1261 benign 0.19 Stabilizing 0.017 N 0.503 neutral N 0.473445403 None None N
K/L 0.1287 likely_benign 0.1544 benign 0.19 Stabilizing None N 0.255 neutral None None None None N
K/M 0.1042 likely_benign 0.1242 benign 0.172 Stabilizing 0.138 N 0.463 neutral None None None None N
K/N 0.1227 likely_benign 0.143 benign -0.423 Destabilizing 0.007 N 0.321 neutral N 0.485417275 None None N
K/P 0.3428 ambiguous 0.3952 ambiguous -0.086 Destabilizing 0.085 N 0.425 neutral None None None None N
K/Q 0.0841 likely_benign 0.1041 benign -0.548 Destabilizing None N 0.111 neutral N 0.38680643 None None N
K/R 0.0954 likely_benign 0.1123 benign -0.557 Destabilizing 0.007 N 0.323 neutral N 0.440572741 None None N
K/S 0.152 likely_benign 0.1792 benign -1.172 Destabilizing 0.004 N 0.222 neutral None None None None N
K/T 0.0708 likely_benign 0.0834 benign -0.855 Destabilizing 0.014 N 0.334 neutral N 0.380129835 None None N
K/V 0.1026 likely_benign 0.1255 benign -0.086 Destabilizing 0.009 N 0.321 neutral None None None None N
K/W 0.6093 likely_pathogenic 0.6511 pathogenic -0.316 Destabilizing 0.788 D 0.493 neutral None None None None N
K/Y 0.3318 likely_benign 0.3686 ambiguous -0.023 Destabilizing 0.085 N 0.57 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.